The Efficacy of Combination Therapy in Atrophic Scars
Launched by ASSIUT UNIVERSITY · Mar 6, 2024
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effectiveness of a combination therapy for treating atrophic scars, which are sunken scars often caused by injuries or skin conditions like acne. Many people with these types of scars struggle with their appearance and how it affects their daily lives. The study aims to find out if using different treatment methods together can improve the results for patients with these scars, as there is currently no standard treatment that works best for everyone.
To participate in this trial, individuals aged 12 to 60 who have post-inflammatory, post-traumatic, or post-operative atrophic scars may be eligible. However, those with active skin infections or post-acne scars will not be included. Participants will undergo treatments that may involve various methods, and the trial will use ultrasound technology to assess how well the treatments are working without needing invasive procedures. This study is important as it could help develop better treatment options for those suffering from atrophic scars.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients aged from 12 to 60 years with
- • post inflammatory atrophic scar.
- • post traumatic atrophic scar.
- • post operative atrophic scar
- Exclusion Criteria:
- • post acne scar.
- • active skin infection.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported